Saturday, December 27, 2014 2:36:29 PM
Harold Dvorak : Peregrine Pharmaceuticals KOL : Cancer starts with Inflammation : Part II
...chronic inflammation fuels cancer.
The association between chronic inflammation and tumor development has long been known from the early work of German pathologist Rudolph Virchow. Harvard University pathologist Dr. Harold Dvorak later compared tumors with “wounds that never heal,” noting the similarities between normal inflammation processes that characterize wound healing and tumorigenesis or tumor formation.
It looks like it is now going to be well known in 2015 that with infection, comes inflammation and with chronic inflammation ( that can last for years!) will eventually bring on cancer. Whether those stressed cells and inflammation continue fast with the help of a diet that allows it to maintain course or continues slow with the help of a diet that limits its progression, it seems that without targeting flipped PS, there is no stopping the progression at times, if the immune system is not working at its highest degree. Even if the immune system is working at its highest degree, sometimes inflammation can not be stopped.
It seems as though the general investing public are unable to put the puzzle together that chronic inflammation that began with some infection can be stopped with the help of targeting flipped PS and cancer will not be the deadly disease as we know now it to be with PS targeting, targeted combination therapy.
------------------------------------------------
Some ask: "What causes chronic inflammation?"
http://www.sciencedaily.com/news/health_medicine/immune_system/
-----------------------------------------------
The Immune System - in more detail...
2004
Conclusion
Although rather long and complex, our presentation is just a glimpse of the immune system and the intricate ways in which its various parts interact. Immunity is a fascinating subject that still conceals many secrets. When the immune system is fully understood, it will most likely hold the key to ridding humankind of many of its most feared diseases.
http://www.nobelprize.org/educational/medicine/immunity/immune-detail.html
-------------------------------------------
Time for some coconut oil ...
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
